Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 2a,Condition 2b,Condition 3a,Condition 3b,Condition 4 401,PhysGen Biochemistry data,blood alkaline phosphatase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000577,serum alkaline phosphatase activity level,,,,299.5,U/l,10.5654,33.4107,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),36380,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alkaline phosphatase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000577,serum alkaline phosphatase activity level,,,,384.2,U/l,13.3215,42.1263,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),36384,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood sodium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000500,serum sodium level,,,,141.8,mmol/l,0.5735,1.8135,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),36510,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood sodium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000500,serum sodium level,,,,142,mmol/l,0.6498,2.0548,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),36522,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood creatinine amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000537,plasma creatinine level,,,,0.24,mg/dl,0.0306,0.0966,MMO:0000354,automated plasma creatinine analysis,,,,,,,control condition (for 14 days),42666,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood creatinine amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000537,plasma creatinine level,,,,0.27,mg/dl,0.03,0.0949,MMO:0000354,automated plasma creatinine analysis,,,,,,,control condition (for 14 days),42678,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,32.21,g/dl,0.1345,0.4254,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),37348,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,32.39,g/dl,0.1312,0.4149,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),37360,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood chloride amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000489,serum chloride level,,,,105.2,mmol/l,0.8273,2.6162,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),39122,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,leukocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000365,total white blood cell count,,,,5.29,x 1000 cells/ul,0.2248,0.7109,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),40927,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,leukocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000365,total white blood cell count,,,,6.05,x 1000 cells/ul,0.3591,1.1355,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),40931,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood aspartate transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000581,serum aspartate aminotransferase activity level,,,,99.5556,U/l,6.0072,18.0216,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),42771,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood aspartate transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000581,serum aspartate aminotransferase activity level,,,,93.1,U/l,5.8489,18.4959,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),42775,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alkaline phosphatase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000577,serum alkaline phosphatase activity level,,,,204.1,U/l,8.5628,27.0779,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37470,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alkaline phosphatase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000577,serum alkaline phosphatase activity level,,,,280.4,U/l,16.3729,51.7756,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37482,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000025,red blood cell count,,,,9.06,x 10E6 cells/ul,0.1296,0.4098,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),39238,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000025,red blood cell count,,,,9.546,x 10E6 cells/ul,0.1767,0.5589,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),39242,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood globulin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0002399,serum globulin level,,"replaced obsolete serum globulin level term, 1/19/2016",,1.29,g/dl,0.0433,0.137,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),41047,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood globulin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0002399,serum globulin level,,"replaced obsolete serum globulin level term, 1/19/2016",,1.38,g/dl,0.0416,0.1317,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),41059,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bilirubin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000376,serum total bilirubin level,,,,0.1,mg/dl,0.0,0.0,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),42903,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood phosphate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000542,serum phosphate level,,,,7.9,mg/dl,0.1874,0.5925,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),37595,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood phosphate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000542,serum phosphate level,,,,8.19,mg/dl,0.2755,0.8711,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),37599,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood sodium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000500,serum sodium level,,,,140.5,mmol/l,0.5217,1.6499,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),39389,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood sodium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000500,serum sodium level,,,,140.5,mmol/l,0.6708,2.1213,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),39393,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bilirubin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000376,serum total bilirubin level,,,,0.12,mg/dl,0.0133,0.0422,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),42915,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bicarbonate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000488,serum bicarbonate level,,,,20.4,mmol/l,1.875,5.9292,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),43010,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bicarbonate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000488,serum bicarbonate level,,,,20.8,mmol/l,2.1592,6.828,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),43022,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alanine transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000575,serum alanine aminotransferase activity level,,,,45.6,U/l,1.2667,4.0056,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37727,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood creatinine amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000537,plasma creatinine level,,,,0.27,mg/dl,0.0213,0.0675,MMO:0000354,automated plasma creatinine analysis,,,,,,,air oxygen content (12 %) (for 14 days),39577,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood glucose amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000543,serum glucose level,,,,168,mg/dl,15.0207,47.4997,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),41214,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood glucose amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000543,serum glucose level,,,,177.9,mg/dl,26.1102,82.5677,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),41226,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood potassium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000495,serum potassium level,,,,4.71,mmol/l,0.3107,0.9826,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),43347,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood potassium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000495,serum potassium level,,,,4.96,mmol/l,0.2591,0.8195,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),43359,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alanine transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000575,serum alanine aminotransferase activity level,,,,55.5,U/l,2.9183,9.2286,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37739,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood phosphate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000542,serum phosphate level,,,,8.52,mg/dl,0.4702,1.4868,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37847,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood creatinine amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000537,plasma creatinine level,,,,0.3,mg/dl,0.0211,0.0667,MMO:0000354,automated plasma creatinine analysis,,,,,,,air oxygen content (12 %) (for 14 days),39581,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,monocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000032,blood monocyte count,,,,0.164,x 1000 cells/ul,0.0531,0.1679,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),39675,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,monocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000032,blood monocyte count,,,,0.255,x 1000 cells/ul,0.0607,0.1919,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),39679,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,40.77,%,1.2157,3.8445,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),41322,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,43.8,%,1.2148,3.8416,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),41334,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood phosphate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000542,serum phosphate level,,,,8.91,mg/dl,0.5585,1.766,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37859,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,31.79,g/dl,0.0936,0.2961,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),39778,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,32.34,g/dl,0.0562,0.1776,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),39782,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,eosinophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000033,blood eosinophil count,,,,0.05,x 1000 cells/ul,0.019,0.06,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),41424,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,eosinophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000033,blood eosinophil count,,,,0.021,x 1000 cells/ul,0.009,0.0285,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),41436,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,lymphocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000031,blood lymphocyte count,,,,4.477,x 1000 cells/ul,0.2017,0.6378,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),41504,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,lymphocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000031,blood lymphocyte count,,,,4.911,x 1000 cells/ul,0.2643,0.8357,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),41508,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000026,blood hemoglobin level,,,,16.81,g/dl,0.2364,0.7475,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),37969,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000026,blood hemoglobin level,,,,17.39,g/dl,0.2904,0.9183,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),37973,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood potassium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000495,serum potassium level,,,,4.45,mmol/l,0.1827,0.5778,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),38067,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood potassium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000495,serum potassium level,,,,4.44,mmol/l,0.1962,0.6204,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),38071,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,leukocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000365,total white blood cell count,,,,3.38,x 1000 cells/ul,0.346,1.0942,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),39905,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,leukocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000365,total white blood cell count,,,,4.49,x 1000 cells/ul,0.3348,1.0588,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),39917,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,eosinophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000033,blood eosinophil count,,,,0.041,x 1000 cells/ul,0.0127,0.0401,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),41648,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood chloride amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000489,serum chloride level,,,,105.6,mmol/l,0.5207,1.6465,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),40026,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood chloride amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000489,serum chloride level,,,,105.3,mmol/l,0.4485,1.4181,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),40038,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,eosinophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000033,blood eosinophil count,,,,0.031,x 1000 cells/ul,0.0104,0.0328,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),41652,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,ion homeostasis trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000066,plasma anion gap,,,,17.9,mmol/l,0.5044,1.5951,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),38262,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,ion homeostasis trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000066,plasma anion gap,,,,19.4,mmol/l,0.5812,1.8379,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),38266,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000026,blood hemoglobin level,,,,13.12,g/dl,0.3714,1.1745,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),40122,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000026,blood hemoglobin level,,,,14.2,g/dl,0.3618,1.1441,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),40134,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood urea nitrogen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000587,serum urea nitrogen level,,,,17.2,mg/dl,1.2092,3.8239,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),41772,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood urea nitrogen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000587,serum urea nitrogen level,,,,13.8,mg/dl,0.8406,2.6583,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),41784,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bilirubin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000376,serum total bilirubin level,,,,0.115,mg/dl,0.015,0.0474,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),41869,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bilirubin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000376,serum total bilirubin level,,,,0.11,mg/dl,0.01,0.0316,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),41873,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,ion homeostasis trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000066,plasma anion gap,,,,20.5,mmol/l,1.5794,4.9944,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),43151,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,ion homeostasis trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000066,plasma anion gap,,,,20.8,mmol/l,1.7814,5.6332,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),43163,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,neutrophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000030,blood neutrophil count,,,,0.592,x 1000 cells/ul,0.0826,0.2611,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),43225,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,neutrophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000030,blood neutrophil count,,,,0.851,x 1000 cells/ul,0.1099,0.3475,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),43229,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000290,mean corpuscular hemoglobin,,,,17.51,pg,0.0657,0.2079,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),40218,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000290,mean corpuscular hemoglobin,,,,16.72,pg,0.0442,0.1398,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),40230,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000025,red blood cell count,,,,7.494,x 10E6 cells/ul,0.2277,0.72,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),41989,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood calcium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000503,serum calcium level,,,,9.36,mg/dl,0.136,0.43,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),36625,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood calcium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000503,serum calcium level,,,,9.64,mg/dl,0.1318,0.4169,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),36629,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood cholesterol amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000363,serum total cholesterol level,,,,76.1,mg/dl,2.041,6.4541,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),38453,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood cholesterol amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000363,serum total cholesterol level,,,,79.4,mg/dl,2.68,8.4748,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),38465,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood glucose amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000543,serum glucose level,,,,138.5,mg/dl,5.496,17.3797,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),38531,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood glucose amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,9,,CMO:0000543,serum glucose level,,,,147.8889,mg/dl,4.7095,14.1284,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),38535,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,monocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000032,blood monocyte count,,,,0.04,x 1000 cells/ul,0.0147,0.0464,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),40314,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,monocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000032,blood monocyte count,,,,0.07,x 1000 cells/ul,0.0341,0.1077,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),40326,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000025,red blood cell count,,,,8.476,x 10E6 cells/ul,0.2203,0.6966,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),42001,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bicarbonate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000488,serum bicarbonate level,,,,20.5,mmol/l,0.9098,2.8771,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),42063,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood bicarbonate amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000488,serum bicarbonate level,,,,20.4,mmol/l,0.8718,2.7568,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),42067,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood calcium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000503,serum calcium level,,,,9.47,mg/dl,0.1086,0.3433,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),36779,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood calcium amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000503,serum calcium level,,,,9.39,mg/dl,0.113,0.3573,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),36791,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood albumin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000550,serum albumin level,,,,3.76,g/dl,0.0636,0.2011,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),40427,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood albumin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000550,serum albumin level,,,,3.79,g/dl,0.1005,0.3178,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),40439,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,lymphocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000031,blood lymphocyte count,,,,2.847,x 1000 cells/ul,0.3125,0.9883,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),36889,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,lymphocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000031,blood lymphocyte count,,,,3.58,x 1000 cells/ul,0.3301,1.0438,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),36901,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte size trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000038,mean corpuscular volume,,,,54.4,fl,0.1585,0.5011,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),38667,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte size trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000038,mean corpuscular volume,,,,51.66,fl,0.2437,0.7706,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),38679,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte size trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000038,mean corpuscular volume,,,,58.33,fl,0.162,0.5122,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),38746,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte size trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000038,mean corpuscular volume,,,,56.36,fl,0.2634,0.8329,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),38750,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood globulin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0002399,serum globulin level,,"replaced obsolete serum globulin level term, 1/19/2016",,1.34,g/dl,0.0221,0.0699,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),40551,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood globulin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0002399,serum globulin level,,"replaced obsolete serum globulin level term, 1/19/2016",,1.5,g/dl,0.0333,0.1054,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),40555,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood albumin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000550,serum albumin level,,,,3.88,g/dl,0.0389,0.1229,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),42234,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood albumin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000550,serum albumin level,,,,3.89,g/dl,0.0567,0.1792,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),42238,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood total protein amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000661,serum total protein level,,,,5.22,g/dl,0.0512,0.1619,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),36963,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood total protein amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000661,serum total protein level,,,,5.39,g/dl,0.0809,0.2558,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),36967,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alanine transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000575,serum alanine aminotransferase activity level,,,,46.6,U/l,2.9181,9.228,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),40715,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood alanine transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000575,serum alanine aminotransferase activity level,,,,53.7,U/l,3.1057,9.8212,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),40719,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood aspartate transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000581,serum aspartate aminotransferase activity level,,,,96.7,U/l,6.4413,20.3691,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),42437,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood aspartate transaminase amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000581,serum aspartate aminotransferase activity level,,,,113,U/l,11.2714,35.6433,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),42449,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood cholesterol amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000363,serum total cholesterol level,,,,59.4,mg/dl,2.1197,6.7032,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),37098,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood cholesterol amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000363,serum total cholesterol level,,,,75,mg/dl,2.1654,6.8475,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),37102,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,neutrophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000030,blood neutrophil count,,,,0.438,x 1000 cells/ul,0.1061,0.3354,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),38916,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,neutrophil quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000030,blood neutrophil count,,,,0.821,x 1000 cells/ul,0.1172,0.3707,MMO:0000146,automated blood cell counting method,,,,,,,control condition (for 14 days),38928,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,52.84,%,0.7996,2.5286,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),38992,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,53.77,%,0.9164,2.8979,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),38996,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood urea nitrogen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000587,serum urea nitrogen level,,,,19.8,mg/dl,1.5188,4.8028,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),40829,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood urea nitrogen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000587,serum urea nitrogen level,,,,21,mg/dl,1.4682,4.6428,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),40833,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000290,mean corpuscular hemoglobin,,,,18.56,pg,0.0702,0.2221,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),42546,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood hemoglobin amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000290,mean corpuscular hemoglobin,,,,18.22,pg,0.0727,0.23,MMO:0000146,automated blood cell counting method,,,,,,,air oxygen content (12 %) (for 14 days),42550,air oxygen content (12 %) (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood total protein amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000661,serum total protein level,,,,5.05,g/dl,0.1025,0.324,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37218,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood total protein amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000661,serum total protein level,,,,5.17,g/dl,0.1174,0.3713,MMO:0000169,standard blood chemistry panel,,,,,,,control condition (for 14 days),37230,control condition (for 14 days),,,,,, 401,PhysGen Biochemistry data,blood chloride amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000489,serum chloride level,,,,106.6,mmol/l,0.718,2.2706,MMO:0000169,standard blood chemistry panel,,,,,,,air oxygen content (12 %) (for 14 days),39118,air oxygen content (12 %) (for 14 days),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000531,percent change in respiration rate,,,,139.2725,%,6.4956,21.5434,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),54328,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000531,percent change in respiration rate,,,,128.5562,%,7.4405,22.3215,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),54332,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000532,percent change in tidal volume,,,,146.5344,%,8.6812,28.7922,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),54427,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000532,percent change in tidal volume,,,,141.9371,%,3.4726,10.9812,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),54431,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000222,tidal volume,,,,0.2833,ml,0.0202,0.0669,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),13924,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000222,tidal volume,,,,0.3328,ml,0.028,0.0839,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),13928,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000288,percent change in ventilation,%change=VE during 2-3 min hypercapnia/control during standard conditions,,,257.1314,%,13.9466,46.2557,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),19212,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000288,percent change in ventilation,%change=VE during 2-3 min hypercapnia/control during standard conditions,,,240.82,%,16.6829,52.7559,MMO:0000022,stop flow air displacement plethysmography,,0,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),19216,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000288,percent change in ventilation,%change=VE during 2-3 min hypoxia/control during standard conditions,,,141.3502,%,16.2583,48.7748,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),13685,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,7,,CMO:0000009,mean arterial blood pressure,,,,119.4943,mmHg,2.4915,6.5918,MMO:0000013,vascular fluid filled catheter,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),13484,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,7,,CMO:0000009,mean arterial blood pressure,,,,123.4129,mmHg,4.6795,12.3809,MMO:0000013,vascular fluid filled catheter,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),13494,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000015,body temperature,,,,36.8364,degrees C,0.1749,0.5801,MMO:0000034,digital rectal thermometry,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),13560,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000015,body temperature,,,,36.14,degrees C,0.1607,0.5082,MMO:0000034,digital rectal thermometry,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),13564,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000288,percent change in ventilation,%change=VE during7-9 min hypercapnia/control during standard conditions,,,134.9358,%,11.2613,33.784,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),18548,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000288,percent change in ventilation,%change=VE during7-9 min hypercapnia/control during standard conditions,,,121.4356,%,11.8817,39.4072,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),18544,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000288,percent change in ventilation,%change=VE during7-9 min hypercapnia/control during standard conditions,,,208.6069,%,11.6832,36.9455,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),14203,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000288,percent change in ventilation,%change=VE during7-9 min hypercapnia/control during standard conditions,,,233.6396,%,22.2227,73.7043,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),14199,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000532,percent change in tidal volume,,,,96.7738,%,7.6004,25.2075,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),53988,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000532,percent change in tidal volume,,,,106.8449,%,6.2682,18.8045,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),53992,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000531,percent change in respiration rate,,,,156.6755,%,7.1919,23.8528,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),54221,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000531,percent change in respiration rate,,,,146.3656,%,6.0828,19.2356,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),54225,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000532,percent change in tidal volume,,,,153.2432,%,9.0555,30.0336,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),54087,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000532,percent change in tidal volume,,,,151.9376,%,4.0538,12.8193,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),54091,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood acidity-alkalinity balance trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,6,,CMO:0000300,absolute change in blood pH,,,,0.0467,,0.0101,0.0247,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),19784,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood acidity-alkalinity balance trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000300,absolute change in blood pH,,,,0.0498,,0.0046,0.0112,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),19794,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000222,tidal volume,,,,0.4014,ml,0.0193,0.064,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),16474,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000222,tidal volume,,,,0.4538,ml,0.0414,0.1311,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),16478,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,7,,CMO:0000009,mean arterial blood pressure,,,,119.3,mmHg,2.5363,6.7104,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,19865,control condition,,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,7,,CMO:0000009,mean arterial blood pressure,,,,125.5043,mmHg,3.8768,10.257,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,19875,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000132,minute ventilation,,,,63.9918,ml/min,2.8863,9.5727,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),14501,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000132,minute ventilation,,,,69.8785,ml/min,7.986,25.254,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),14505,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000289,respiration rate,,,,140.1305,breaths/min,7.4497,24.7078,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),18266,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000289,respiration rate,,,,135.4833,breaths/min,3.0592,9.1775,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),18270,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000531,percent change in respiration rate,,,,122.51,%,6.0689,20.1284,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),53755,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000531,percent change in respiration rate,,,,126.9383,%,8.4674,25.4023,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),53759,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000532,percent change in tidal volume,,,,103.8797,%,9.221,30.5827,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),53887,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000532,percent change in tidal volume,,,,108.5606,%,7.9009,23.7027,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),53891,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000015,body temperature,,,,36.9,degrees C,0.1789,0.5933,MMO:0000034,digital rectal thermometry,,,,,,,air oxygen content (12 %) (for 0.1 hours),16573,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000015,body temperature,,,,36.8444,degrees C,0.0801,0.2404,MMO:0000034,digital rectal thermometry,,,,,,,air oxygen content (12 %) (for 0.1 hours),16577,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,7,,CMO:0000002,heart rate,,,,361.0329,beats/min,16.1619,42.7605,MMO:0000013,vascular fluid filled catheter,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),14697,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000531,percent change in respiration rate,,,,169.074,%,6.2604,20.7636,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),53636,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000531,percent change in respiration rate,,,,157.4148,%,7.4685,23.6176,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),53640,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,7,,CMO:0000002,heart rate,,,,309.1186,beats/min,11.1501,29.5004,MMO:0000013,vascular fluid filled catheter,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),14707,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000289,respiration rate,,,,122.3345,breaths/min,4.5327,15.0331,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),14795,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000289,respiration rate,,,,133.4993,breaths/min,4.8992,14.6976,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),14799,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000015,body temperature,,,,36.57,degrees C,0.1146,0.3622,MMO:0000034,digital rectal thermometry,,,,,,,control condition,19074,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000132,minute ventilation,,,,57.0715,ml/min,3.654,12.1191,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),20762,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000132,minute ventilation,,,,61.3436,ml/min,8.395,26.5473,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),20766,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood oxygen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,6,,CMO:0000299,absolute change in partial pressure of blood oxygen,,,,-43.7083,mmHg,4.1216,10.0959,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),19463,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood oxygen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000299,absolute change in partial pressure of blood oxygen,,,,-44.8,mmHg,2.0797,5.0942,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),19474,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000222,tidal volume,,,,0.2626,ml,0.0215,0.0712,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),15234,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000222,tidal volume,,,,0.3291,ml,0.0251,0.0754,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),15238,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood acidity-alkalinity balance trait,"Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,6,,CMO:0000379,blood pH,,,,7.4884,,0.0115,0.0282,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),17048,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood acidity-alkalinity balance trait,"Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000379,blood pH,,,,7.5006,,0.0032,0.0079,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),17059,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood carbon dioxide amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,37.1938,mmHg,1.2873,3.6411,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,control condition,16067,control condition,,,,,, 381,PhysGen Respiratory data,body mass,Moms and pups used in studies were fed Dyets,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000012,body weight,,,,183.5,g,5.2,17.2,MMO:0000017,whole body digital scale,,,,,,,control condition,17818,control condition,,,,,, 381,PhysGen Respiratory data,body mass,Moms and pups used in studies were fed Dyets,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000012,body weight,,,,250.1,g,6.2,19.6,MMO:0000017,whole body digital scale,,,,,,,control condition,17822,control condition,,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000009,mean arterial blood pressure,,,,116.7362,mmHg,5.8186,16.4575,MMO:0000013,vascular fluid filled catheter,,,,,,,air oxygen content (12 %) (for 0.1 hours),14330,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000009,mean arterial blood pressure,,,,115.4283,mmHg,1.8185,4.4544,MMO:0000013,vascular fluid filled catheter,,,,,,,air oxygen content (12 %) (for 0.1 hours),14341,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood carbon dioxide amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,36.3,mmHg,1.1843,2.901,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,control condition,16078,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000132,minute ventilation,,,,32.0066,ml/min,2.6623,8.8299,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),20209,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000132,minute ventilation,,,,43.8687,ml/min,3.5445,10.6335,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0.1 and 0.1 hours),20213,air oxygen content (12 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood acidity-alkalinity balance trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000379,blood pH,,,,7.4402,,0.0097,0.0274,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,control condition,20623,control condition,,,,,, 381,PhysGen Respiratory data,blood acidity-alkalinity balance trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000379,blood pH,,,,7.4507,,0.0043,0.0105,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,control condition,20633,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000132,minute ventilation,,,,25.4455,ml/min,1.5182,5.0353,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,16148,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000132,minute ventilation,,,,29.1499,ml/min,2.7323,8.6401,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,16152,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000132,minute ventilation,,,,31.5082,ml/min,5.7747,19.1526,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,16691,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000132,minute ventilation,,,,34.6144,ml/min,4.3019,12.9056,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,16695,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000288,percent change in ventilation,%change=VE during 2-3 min hypoxia/control during standard conditions,,,148.0066,%,16.0437,53.2109,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),13681,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000289,respiration rate,,,,101.5711,breaths/min,4.8039,15.9328,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,18411,control condition,,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000289,respiration rate,,,,107.9758,breaths/min,6.1761,18.5284,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,18415,control condition,,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000289,respiration rate,,,,148.0616,breaths/min,4.4711,14.8291,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),17112,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000289,respiration rate,,,,141.4958,breaths/min,3.9438,12.4715,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),17116,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood carbon dioxide amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,6,,CMO:0000298,absolute change in partial pressure of blood carbon dioxide,,,,-8.05,mmHg,0.5701,1.3964,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),19632,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood oxygen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000381,partial pressure of blood oxygen,,,,98.9312,mmHg,5.2254,14.7796,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,control condition,18867,control condition,,,,,, 381,PhysGen Respiratory data,blood oxygen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000381,partial pressure of blood oxygen,,,,95.8417,mmHg,2.7975,6.8523,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,control condition,18878,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000222,tidal volume,,,,0.2968,ml,0.0376,0.1246,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,17983,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000222,tidal volume,,,,0.3137,ml,0.0261,0.0782,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,17987,control condition,,,,,, 381,PhysGen Respiratory data,blood carbon dioxide amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000298,absolute change in partial pressure of blood carbon dioxide,,,,-6.4333,mmHg,0.7772,1.9039,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),19643,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000699,absolute change in body temperature,,,,0.0636,degrees C,0.2424,0.8041,MMO:0000034,digital rectal thermometry,,,,,,,air oxygen content (12 %) (for 0.1 hours),20310,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000699,absolute change in body temperature,,,,0.0667,degrees C,0.1354,0.4062,MMO:0000034,digital rectal thermometry,,,,,,,air oxygen content (12 %) (for 0.1 hours),20314,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000289,respiration rate,,,,95.6677,breaths/min,3.4167,11.3318,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,14936,control condition,,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000289,respiration rate,,,,97.5491,breaths/min,3.0942,9.7847,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,14940,control condition,,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000002,heart rate,,,,413.0288,beats/min,15.541,43.9567,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,20921,control condition,,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,5,,CMO:0000002,heart rate,,,,405.508,beats/min,33.4426,74.78,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,20932,control condition,,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000015,body temperature,,,,36.8364,degrees C,0.1422,0.4717,MMO:0000034,digital rectal thermometry,,,,,,,control condition,16813,control condition,,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000015,body temperature,,,,36.7778,degrees C,0.1115,0.3346,MMO:0000034,digital rectal thermometry,,,,,,,control condition,16817,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000222,tidal volume,,,,0.2665,ml,0.012,0.0398,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,15398,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000222,tidal volume,,,,0.2977,ml,0.0248,0.0786,MMO:0000022,stop flow air displacement plethysmography,,,,,,,control condition,15402,control condition,,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000699,absolute change in body temperature,,,,-0.2182,degrees C,0.1793,0.5947,MMO:0000034,digital rectal thermometry,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),15670,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000699,absolute change in body temperature,,,,-0.43,degrees C,0.1407,0.4448,MMO:0000034,digital rectal thermometry,,,,,,,air carbon dioxide content (7 %) (for 0.1 hours),15674,air carbon dioxide content (7 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood gas amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,6,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,28.9583,mmHg,0.9114,2.2326,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),17240,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood gas amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000283,partial pressure of blood carbon dioxide (Pco2),,,,29.8667,mmHg,1.2182,2.9841,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),17251,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000002,heart rate,,,,394.4538,beats/min,17.9283,50.709,MMO:0000013,vascular fluid filled catheter,,,,,,,air oxygen content (12 %) (for 0.1 hours),17503,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000002,heart rate,,,,395.9167,beats/min,8.6141,21.1002,MMO:0000013,vascular fluid filled catheter,,,,,,,air oxygen content (12 %) (for 0.1 hours),17514,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,8,,CMO:0000009,mean arterial blood pressure,,,,119.35,mmHg,2.4161,6.8337,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,15092,control condition,,,,,, 381,PhysGen Respiratory data,arterial blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,5,,CMO:0000009,mean arterial blood pressure,,,,122.624,mmHg,4.7555,10.6336,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,15103,control condition,,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000289,respiration rate,,,,160.5235,breaths/min,5.3479,17.7371,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),16912,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,respiratory function trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000289,respiration rate,,,,152.1659,breaths/min,5.1154,16.1763,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0 and 0.1 hours),16916,air carbon dioxide content (7 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000132,minute ventilation,,,,39.5638,ml/min,3.2276,10.7046,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),18663,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000222,tidal volume,,,,0.3838,ml,0.0187,0.0621,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),17371,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,10,,CMO:0000222,tidal volume,,,,0.4261,ml,0.0445,0.1407,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),17375,air carbon dioxide content (7 %) (between 0.1 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,7,,CMO:0000002,heart rate,,,,395.6843,beats/min,10.8769,28.7774,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,15927,control condition,,,,,, 381,PhysGen Respiratory data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,7,,CMO:0000002,heart rate,,,,378.8014,beats/min,6.7596,17.8842,MMO:0000013,vascular fluid filled catheter,,,,,,,control condition,15937,control condition,,,,,, 381,PhysGen Respiratory data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,9,,CMO:0000132,minute ventilation,,,,45.2492,ml/min,4.1586,12.4758,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (between 0 and 0.1 hours),18667,air oxygen content (12 %) (between 0 and 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood oxygen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,6,,CMO:0000381,partial pressure of blood oxygen,,,,54.3083,mmHg,2.7735,6.7937,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),20475,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,blood oxygen amount,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 82 days,6,,CMO:0000381,partial pressure of blood oxygen,,,,51.0417,mmHg,1.5528,3.8036,MMO:0000036,automated blood gas analysis using a Bayer analyzer,,,,,,,air oxygen content (12 %) (for 0.1 hours),20486,air oxygen content (12 %) (for 0.1 hours),,,,,, 381,PhysGen Respiratory data,body temperature trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 82 days,11,,CMO:0000015,body temperature,,,,37.0545,degrees C,0.1569,0.5203,MMO:0000034,digital rectal thermometry,,,,,,,control condition,19070,control condition,,,,,, 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000069,heart wet weight,,,,0.927,g,0.0364,0.1151,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),45406,air oxygen content (12 %) (for 14 days),,,,,, 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000069,heart wet weight,,,,1.014,g,0.0256,0.081,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),45410,air oxygen content (12 %) (for 14 days),,,,,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,6.699,ml/min/g,1.2802,4.0483,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44719,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,4.773,ml/min/g,0.4553,1.4399,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44723,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000007,left ventricular systolic blood pressure,,,,96.6511,mmHg,7.8065,23.4195,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44816,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000007,left ventricular systolic blood pressure,,,,108.5911,mmHg,6.3769,19.1308,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44820,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,2,,CMO:0000754,percent change in left ventricular systolic blood pressure,post-ischemic value/pre-ischemic value x 100%,,,73.194,%,30.608,43.2862,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44919,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,6,,CMO:0000754,percent change in left ventricular systolic blood pressure,post-ischemic value/pre-ischemic value x 100%,,,106.7137,%,8.5529,20.9502,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44923,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,7,,CMO:0000002,heart rate,,,,182.8357,beats/min,19.7834,52.3418,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),45149,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000002,heart rate,,,,196.96,beats/min,9.2117,27.635,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),45153,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000018,left ventricular developed pressure,,,,45.5238,mmHg,10.0881,28.5335,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),45271,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000018,left ventricular developed pressure,,,,43.7811,mmHg,7.2043,21.6128,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),45275,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000007,left ventricular systolic blood pressure,,,,90.6938,mmHg,14.8069,41.8803,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),49889,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000007,left ventricular systolic blood pressure,,,,77.9111,mmHg,11.1272,33.3816,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),49893,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000665,heart contraction pressure,,,,34,mmHg,5.5966,15.8294,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),49998,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000665,heart contraction pressure,,,,29.6667,mmHg,2.9814,8.9443,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50002,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000663,time to onset of heart contraction,,,,980,s,37.0386,111.1159,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50120,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,,, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000663,time to onset of heart contraction,,,,907.5556,s,18.3554,55.0661,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50124,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000664,time to peak heart contraction,,,,1172.5,s,64.1291,181.3844,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50228,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000664,time to peak heart contraction,,,,1155.2222,s,49.556,148.6681,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),50232,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000012,body weight,,,,136.1,g,3.0,9.5,MMO:0000017,whole body digital scale,,,,,,,air oxygen content (12 %) (for 14 days),49529,air oxygen content (12 %) (for 14 days),,,,,, 461,PhysGen Cardiac data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000012,body weight,,,,140,g,8.1,25.8,MMO:0000017,whole body digital scale,,,,,,,air oxygen content (12 %) (for 14 days),49541,air oxygen content (12 %) (for 14 days),,,,,, 461,PhysGen Cardiac data,heart left ventricle integrity trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000695,heart left ventricle infarction weight to total heart left ventricle weight ratio,,,,1.828,%,1.3468,4.2591,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours),49699,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 3 hours) 461,PhysGen Cardiac data,heart left ventricle integrity trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000695,heart left ventricle infarction weight to total heart left ventricle weight ratio,,,,7.381,%,4.1582,13.1494,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours),49703,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 3 hours) 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000069,heart wet weight,,,,0.865,g,0.0452,0.143,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition,49061,control condition,,,,,, 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000069,heart wet weight,,,,1.024,g,0.035,0.1107,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition,49065,control condition,,,,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000006,left ventricular diastolic blood pressure,,,,5.4038,mmHg,0.2253,0.6374,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),49178,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000006,left ventricular diastolic blood pressure,,,,5.3989,mmHg,0.1931,0.5794,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),49182,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000663,time to onset of heart contraction,,,,902.75,s,95.2783,269.4877,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),49300,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000663,time to onset of heart contraction,,,,971.4444,s,41.3273,123.982,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),49304,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),, 461,PhysGen Cardiac data,heart left ventricle integrity trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000695,heart left ventricle infarction weight to total heart left ventricle weight ratio,,,,9.583,%,2.8581,9.038,MMO:0000157,digital scale post excision weight measurement,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours),49397,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 3 hours),, 461,PhysGen Cardiac data,heart left ventricle integrity trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000695,heart left ventricle infarction weight to total heart left ventricle weight ratio,,,,10.873,%,3.3511,10.5971,MMO:0000157,digital scale post excision weight measurement,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours),49401,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 3 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,83.3012,%,5.7279,17.1836,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46067,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,65.4855,%,4.5802,14.484,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46071,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000198,arterial blood flow rate,,,,13.0467,ml/min/g,0.8567,2.5701,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46654,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,12.968,ml/min/g,0.5379,1.701,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46658,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.3402,IU/g,0.0394,0.1245,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47319,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000012,body weight,,,,154,g,1.9,6.1,MMO:0000017,whole body digital scale,,,,,,,control condition,47824,control condition,,,,,, 461,PhysGen Cardiac data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000012,body weight,,,,215.4,g,6.9,21.9,MMO:0000017,whole body digital scale,,,,,,,control condition,47836,control condition,,,,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000018,left ventricular developed pressure,,,,52.49,mmHg,8.9362,26.8087,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47912,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000018,left ventricular developed pressure,,,,56.1578,mmHg,8.535,25.605,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47916,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000665,heart contraction pressure,,,,40.2222,mmHg,3.0812,9.2436,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),48034,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,,, 461,PhysGen Cardiac data,heart muscle contractility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000665,heart contraction pressure,,,,50,mmHg,1.5456,4.6368,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),48038,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000002,heart rate,,,,216.7944,beats/min,15.1959,45.5876,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),48198,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000002,heart rate,,,,255.5667,beats/min,10.7162,32.1485,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),48202,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,7,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,73.3433,%,8.5281,22.5631,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48296,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,84.035,%,4.2158,12.6474,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48300,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,106.215,%,10.5053,29.7136,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48407,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,102.1873,%,12.3276,36.9828,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48411,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,5,,CMO:0000751,percent change in left ventricular developed pressure,post-ischemic value/pre-ischemic value x 100%,,,35.7058,%,7.6168,17.0317,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48528,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,5,,CMO:0000751,percent change in left ventricular developed pressure,post-ischemic value/pre-ischemic value x 100%,,,44.3938,%,6.6601,14.8924,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48532,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,5,,CMO:0000018,left ventricular developed pressure,,,,155.52,mmHg,6.9665,15.5776,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),48625,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,5,,CMO:0000018,left ventricular developed pressure,,,,117.22,mmHg,7.372,16.4843,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),48629,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,5,,CMO:0000754,percent change in left ventricular systolic blood pressure,post-ischemic value/pre-ischemic value x 100%,,,72.9376,%,4.8925,10.94,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48757,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,5,,CMO:0000754,percent change in left ventricular systolic blood pressure,post-ischemic value/pre-ischemic value x 100%,,,76.332,%,6.7365,15.0632,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48761,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,25.7507,IU/g,1.3415,4.2423,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),48868,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 1.5 hours),, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,27.4697,IU/g,1.8009,5.6951,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),48879,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 1.5 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000002,heart rate,,,,268.7822,beats/min,47.0506,141.1517,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48950,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000002,heart rate,,,,219.94,beats/min,39.931,119.793,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48946,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,2,,CMO:0000007,left ventricular systolic blood pressure,,,,118.5,mmHg,2.5,3.5355,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),45505,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,6,,CMO:0000007,left ventricular systolic blood pressure,,,,104.87,mmHg,5.338,13.0754,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),45509,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000198,arterial blood flow rate,,,,6.5422,ml/min/g,0.5297,1.5892,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46202,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,5.687,ml/min/g,0.1677,0.5302,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46206,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,2,,CMO:0000018,left ventricular developed pressure,,,,112.65,mmHg,2.65,3.7477,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46751,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,6,,CMO:0000018,left ventricular developed pressure,,,,99.4367,mmHg,5.1002,12.4928,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46755,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.2595,IU/g,0.0388,0.1227,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47330,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000074,heart weight to body weight ratio,,,,6.823,g/kg,0.261,0.825,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),45627,air oxygen content (12 %) (for 14 days),,,,,, 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000074,heart weight to body weight ratio,,,,7.418,g/kg,0.382,1.208,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),45639,air oxygen content (12 %) (for 14 days),,,,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,2,,CMO:0000751,percent change in left ventricular developed pressure,post-ischemic value/pre-ischemic value x 100%,,,37.0975,%,30.5525,43.2078,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46320,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,6,,CMO:0000751,percent change in left ventricular developed pressure,post-ischemic value/pre-ischemic value x 100%,,,60.114,%,10.3661,25.3916,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46324,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,7.894,ml/min/g,0.4019,1.2708,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46871,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,8.999,ml/min/g,0.561,1.7739,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46875,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,,,, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.5125,IU/g,0.0923,0.2769,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47456,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.5219,IU/g,0.0658,0.2081,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47466,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,5,,CMO:0000007,left ventricular systolic blood pressure,,,,161.54,mmHg,7.0128,15.6811,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),45730,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,5,,CMO:0000007,left ventricular systolic blood pressure,,,,123.32,mmHg,7.4326,16.6198,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),45734,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000006,left ventricular diastolic blood pressure,,,,45.17,mmHg,9.9708,28.2017,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46418,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000006,left ventricular diastolic blood pressure,,,,34.13,mmHg,5.4197,16.2592,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46422,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000074,heart weight to body weight ratio,,,,5.612,g/kg,0.274,0.865,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition,47002,control condition,,,,,, 461,PhysGen Cardiac data,heart mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000074,heart weight to body weight ratio,,,,4.78,g/kg,0.174,0.552,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition,47014,control condition,,,,,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,44.0071,%,2.5139,7.9497,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47078,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,37.145,%,3.6578,11.5671,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47082,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,7,,CMO:0000002,heart rate,,,,251.7943,beats/min,5.9229,15.6705,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47583,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000002,heart rate,,,,235.5222,beats/min,6.2882,18.8647,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47587,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000664,time to peak heart contraction,,,,1199.7778,s,33.2026,99.6077,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),46549,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,,, 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000664,time to peak heart contraction,,,,1152.6667,s,25.9556,77.8669,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours),46553,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,6,,CMO:0000006,left ventricular diastolic blood pressure,,,,5.95,mmHg,0.1765,0.4324,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47198,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,8,,CMO:0000006,left ventricular diastolic blood pressure,,,,5.53,mmHg,0.3369,0.9528,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47202,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,,, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,9,,CMO:0000006,left ventricular diastolic blood pressure,,,,44.1611,mmHg,4.0338,12.1013,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47702,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart left ventricular blood pressure trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000006,left ventricular diastolic blood pressure,,,,52.4333,mmHg,3.699,11.0969,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47706,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 0.7 hours),, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,22.8159,IU/g,3.4642,10.9549,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),45974,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 1.5 hours) 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,22.8014,IU/g,1.3625,4.3087,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),45982,air oxygen content (12 %) (for 14 days),,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,perfusate suspended (for 0.4 hours),,controlled oxygen content Kreb's solution perfusate (for 1.5 hours) 482,PhysGen Renal B data,urine sodium amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,7,,CMO:0000760,urine sodium excretion rate,,,,18.5163,mEq/d,2.1436,5.6715,MMO:0000039,flame atomic emission spectrometry,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52782,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,urine sodium amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,4,,CMO:0000760,urine sodium excretion rate,,,,21.1452,mEq/d,6.3886,12.7773,MMO:0000039,flame atomic emission spectrometry,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52793,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,renin activity,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,2,,CMO:0000116,plasma renin activity level,,,,3.48,ng/ml/h,1.03,1.4566,MMO:0000073,radioimmunoassay,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52880,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,renin activity,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,2,,CMO:0000116,plasma renin activity level,,,,2.105,ng/ml/h,0.695,0.9829,MMO:0000073,radioimmunoassay,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52891,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,total urine protein amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,7,,CMO:0000756,urine total protein excretion rate,,,,65.0143,mg/d,9.0014,23.8155,MMO:0000359,automated urine total protein analysis,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52096,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,total urine protein amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,4,,CMO:0000756,urine total protein excretion rate,,,,401.0062,mg/d,155.0138,310.0276,MMO:0000359,automated urine total protein analysis,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52107,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,blood creatinine amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,7,,CMO:0000537,plasma creatinine level,,,,0.3271,mg/dl,0.0191,0.0506,MMO:0000073,radioimmunoassay,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52245,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,blood creatinine amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,3,,CMO:0000537,plasma creatinine level,,,,0.31,mg/dl,0.058,0.1004,MMO:0000073,radioimmunoassay,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52256,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,urine potassium amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,7,,CMO:0000761,urine potassium excretion rate,,,,1.1866,mEq/d,0.0842,0.2229,MMO:0000039,flame atomic emission spectrometry,,,urine potassium analysis,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52294,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,urine potassium amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,4,,CMO:0000761,urine potassium excretion rate,,,,1.174,mEq/d,0.098,0.1961,MMO:0000039,flame atomic emission spectrometry,,,urine potassium analysis,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52305,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,glomerular filtration trait,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,6,,CMO:0000765,creatinine clearance,,,,1.3478,ml/min,0.163,0.3992,MMO:0000275,urine creatinine analysis,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52341,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,glomerular filtration trait,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,3,,CMO:0000765,creatinine clearance,,,,1.881,ml/min,0.4317,0.7477,MMO:0000275,urine creatinine analysis,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52352,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,urine albumin amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,7,,CMO:0000757,urine albumin excretion rate,,,,29.5891,mg/d,7.0447,18.6386,MMO:0000073,radioimmunoassay,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52388,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,urine albumin amount,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,4,,CMO:0000757,urine albumin excretion rate,,,,144.625,mg/d,56.9182,113.8364,MMO:0000073,radioimmunoassay,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52399,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,heart pumping trait,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,8,,CMO:0000002,heart rate,,,,429.9016,beats/min,7.7748,21.9906,MMO:0000013,vascular fluid filled catheter,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52486,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,heart pumping trait,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,3,,CMO:0000002,heart rate,,,,404.674,beats/min,22.7435,39.3929,MMO:0000013,vascular fluid filled catheter,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52497,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,arterial blood pressure trait,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,female,99 days to 80 days,8,,CMO:0000009,mean arterial blood pressure,,,,141.229,mmHg,4.5437,12.8516,MMO:0000013,vascular fluid filled catheter,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52533,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 482,PhysGen Renal B data,arterial blood pressure trait,"Moms were fed Teklad, pups used in studies were fed Dyets",RS:0000337,FHH-Chr 8BN/Mcwi,male,99 days to 80 days,3,,CMO:0000009,mean arterial blood pressure,,,,159.6053,mmHg,9.531,16.5082,MMO:0000013,vascular fluid filled catheter,,,,,,,controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),52544,controlled sodium content diet (8 %) (between 19 and 22 days),controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days),,,,, 526,PhysGen Lung data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,40.77,%,1.2157,3.8445,MMO:0000215,microhematocrit tube assay with visual assessment,,,,,,,control condition (for 14 days),57507,control condition (for 14 days),,,,,, 526,PhysGen Lung data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,43.8,%,1.2148,3.8416,MMO:0000215,microhematocrit tube assay with visual assessment,,,,,,,control condition (for 14 days),57519,control condition (for 14 days),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000710,methylene blue metabolism-surface area product after auto-oxidation,,,,19.3371,ml/min/kg,0.6459,2.0425,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours),57599,air oxygen content (12 %) (for 14 days),,methylene blue (10 umol/l) (between 0 and 0 hours),,sample resting period (for 0.1 hours),, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000710,methylene blue metabolism-surface area product after auto-oxidation,,,,16.452,ml/min/kg,0.9013,2.8502,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours),57603,air oxygen content (12 %) (for 14 days),,methylene blue (10 umol/l) (between 0 and 0 hours),,sample resting period (for 0.1 hours),, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000709,methylene blue metabolism-surface area product without auto-oxidation,,,,28.922,ml/min/kg,0.9285,2.9363,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours),57801,air oxygen content (12 %) (for 14 days),,methylene blue (10 umol/l) (between 0 and 0 hours),,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000709,methylene blue metabolism-surface area product without auto-oxidation,,,,24.5022,ml/min/kg,1.497,4.7338,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours),57805,air oxygen content (12 %) (for 14 days),,methylene blue (10 umol/l) (between 0 and 0 hours),,,, 526,PhysGen Lung data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,6,,CMO:0000713,dose of methacholine at which pulmonary conductance is half its pretreatment value,,,,2.9423,mg/kg,0.8848,2.1674,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours),58911,air oxygen content (12 %) (for 14 days),,methacholine (0-11.06 mg/kg) ,drug dose time series (for 0.2 hours),,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000708,FAPGG metabolism-surface area product,,,,66.1666,ml/min/kg,6.7232,20.1696,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,FAPGG (0.6 mmol/l) (between 0 and 0 hours),58246,FAPGG (0.6 mmol/l) (between 0 and 0 hours),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000708,FAPGG metabolism-surface area product,,,,49.8325,ml/min/kg,6.7141,18.9903,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,FAPGG (0.6 mmol/l) (between 0 and 0 hours),58258,FAPGG (0.6 mmol/l) (between 0 and 0 hours),,,,,, 526,PhysGen Lung data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000012,body weight,,,,168.7,g,3.5,11.2,MMO:0000017,whole body digital scale,,,,,,,control condition (for 14 days),58358,control condition (for 14 days),,,,,, 526,PhysGen Lung data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000012,body weight,,,,221.8,g,6.4,20.2,MMO:0000017,whole body digital scale,,,,,,,control condition (for 14 days),58370,control condition (for 14 days),,,,,, 526,PhysGen Lung data,heart right ventricle mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000108,heart right ventricle weight to left ventricle weight ratio,,,,0.4118,,0.0245,0.0734,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),58734,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,heart right ventricle mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000108,heart right ventricle weight to left ventricle weight ratio,,,,0.3792,,0.0348,0.1101,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),58738,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000710,methylene blue metabolism-surface area product after auto-oxidation,,,,15.0472,ml/min/kg,0.7356,2.2069,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours),60014,methylene blue (10 umol/l) (between 0 and 0 hours),,sample resting period (for 0.1 hours),,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000710,methylene blue metabolism-surface area product after auto-oxidation,,,,12.9169,ml/min/kg,1.0294,2.9115,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours),60026,methylene blue (10 umol/l) (between 0 and 0 hours),,sample resting period (for 0.1 hours),,,, 526,PhysGen Lung data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000012,body weight,,,,144.3,g,3.1,9.7,MMO:0000017,whole body digital scale,,,,,,,air oxygen content (12 %) (for 14 days),59063,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000012,body weight,,,,168.4,g,2.8,8.8,MMO:0000017,whole body digital scale,,,,,,,air oxygen content (12 %) (for 14 days),59067,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,7,,CMO:0000713,dose of methacholine at which pulmonary conductance is half its pretreatment value,,,,2.6144,mg/kg,0.356,0.9419,MMO:0000022,stop flow air displacement plethysmography,,,,,,,methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours),59184,methacholine (0-11.06 mg/kg) ,drug dose time series (for 0.2 hours),,,,, 526,PhysGen Lung data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000713,dose of methacholine at which pulmonary conductance is half its pretreatment value,,,,5.1409,mg/kg,1.0463,2.9594,MMO:0000022,stop flow air displacement plethysmography,,,,,,,methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours),59196,methacholine (0-11.06 mg/kg) ,drug dose time series (for 0.2 hours),,,,, 526,PhysGen Lung data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,52.84,%,0.7996,2.5286,MMO:0000215,microhematocrit tube assay with visual assessment,,,,,,,air oxygen content (12 %) (for 14 days),59258,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,erythrocyte quantity,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000037,hematocrit,,,,53.77,%,0.9164,2.8979,MMO:0000215,microhematocrit tube assay with visual assessment,,,,,,,air oxygen content (12 %) (for 14 days),59262,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,blood vessel distensibility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000714,fractional change in blood vessel diameter per unit change in intravascular pressure,,,,0.0284,mmHg-1,0.0038,0.0115,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,Kreb's solution perfusate (between 0.2 and 0.2 hours),59378,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,,,, 526,PhysGen Lung data,blood vessel distensibility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000714,fractional change in blood vessel diameter per unit change in intravascular pressure,,,,0.0286,mmHg-1,0.0056,0.0157,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,Kreb's solution perfusate (between 0.2 and 0.2 hours),59390,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,,,, 526,PhysGen Lung data,lung mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000102,lung dry weight to body weight ratio,,,,1.2585,g/kg,0.0502,0.1588,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition (for 14 days),59474,control condition (for 14 days),,,,,, 526,PhysGen Lung data,lung mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,9,,CMO:0000102,lung dry weight to body weight ratio,,,,1.0552,g/kg,0.0375,0.1126,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition (for 14 days),59486,control condition (for 14 days),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000703,calculated pulmonary vascular resistance normalized to body weight,,,,0.1624,mmHg x min x kg x ml-1,0.0076,0.0239,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours),59548,air oxygen content (12 %) (for 14 days),,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000703,calculated pulmonary vascular resistance normalized to body weight,,,,0.1606,mmHg x min x kg x ml-1,0.01,0.0316,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours),59552,air oxygen content (12 %) (for 14 days),,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,, 526,PhysGen Lung data,lung mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000102,lung dry weight to body weight ratio,,,,1.7612,g/kg,0.0376,0.1189,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),59658,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,lung mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000102,lung dry weight to body weight ratio,,,,1.544,g/kg,0.0256,0.0811,MMO:0000157,digital scale post excision weight measurement,,,,,,,air oxygen content (12 %) (for 14 days),59662,air oxygen content (12 %) (for 14 days),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000711,methylene blue to FAPGG metabolism-surface area product ratio,,,,0.3564,,0.0304,0.0913,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,methylene blue (10 umol/l) (between 0 and 0 hours),59792,methylene blue (10 umol/l) (between 0 and 0 hours),,,,,, 526,PhysGen Lung data,blood vessel distensibility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000714,fractional change in blood vessel diameter per unit change in intravascular pressure,,,,0.0292,mmHg-1,0.0016,0.0049,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours),58490,air oxygen content (12 %) (for 14 days),,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,, 526,PhysGen Lung data,blood vessel distensibility trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000714,fractional change in blood vessel diameter per unit change in intravascular pressure,,,,0.0288,mmHg-1,0.0028,0.0088,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours),58494,air oxygen content (12 %) (for 14 days),,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,, 526,PhysGen Lung data,pulmonary ventilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000713,dose of methacholine at which pulmonary conductance is half its pretreatment value,,,,2.275,mg/kg,0.5522,1.6566,MMO:0000022,stop flow air displacement plethysmography,,,,,,,air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours),58907,air oxygen content (12 %) (for 14 days),,methacholine (0-11.06 mg/kg) ,drug dose time series (for 0.2 hours),,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000711,methylene blue to FAPGG metabolism-surface area product ratio,,,,0.4388,,0.0558,0.1579,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,methylene blue (10 umol/l) (between 0 and 0 hours),59804,methylene blue (10 umol/l) (between 0 and 0 hours),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000703,calculated pulmonary vascular resistance normalized to body weight,,,,0.1014,mmHg x min x kg x ml-1,0.0056,0.0169,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,Kreb's solution perfusate (between 0.2 and 0.2 hours),59908,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000703,calculated pulmonary vascular resistance normalized to body weight,,,,0.1201,mmHg x min x kg x ml-1,0.0086,0.0242,MMO:0000203,fluid-filled catheter with pressure transducer in isolated perfused lung,,,,,,,Kreb's solution perfusate (between 0.2 and 0.2 hours),59920,Kreb's solution perfusate (between 0.2 and 0.2 hours),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,9,,CMO:0000709,methylene blue metabolism-surface area product without auto-oxidation,,,,22.3148,ml/min/kg,1.4801,4.4403,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,methylene blue (10 umol/l) (between 0 and 0 hours),58643,methylene blue (10 umol/l) (between 0 and 0 hours),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,8,,CMO:0000709,methylene blue metabolism-surface area product without auto-oxidation,,,,19.8204,ml/min/kg,1.2112,3.4259,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,methylene blue (10 umol/l) (between 0 and 0 hours),58655,methylene blue (10 umol/l) (between 0 and 0 hours),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000708,FAPGG metabolism-surface area product,,,,54.6284,ml/min/kg,3.997,12.6397,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours),58000,air oxygen content (12 %) (for 14 days),,FAPGG (0.6 mmol/l) (between 0 and 0 hours),,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000708,FAPGG metabolism-surface area product,,,,58.5749,ml/min/kg,4.4464,14.0606,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours),58004,air oxygen content (12 %) (for 14 days),,FAPGG (0.6 mmol/l) (between 0 and 0 hours),,,, 526,PhysGen Lung data,heart right ventricle mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000108,heart right ventricle weight to left ventricle weight ratio,,,,0.2433,,0.0171,0.0542,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition (for 14 days),57921,control condition (for 14 days),,,,,, 526,PhysGen Lung data,heart right ventricle mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000108,heart right ventricle weight to left ventricle weight ratio,,,,0.2158,,0.0095,0.03,MMO:0000157,digital scale post excision weight measurement,,,,,,,control condition (for 14 days),57933,control condition (for 14 days),,,,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,91 days to 77 days,10,,CMO:0000711,methylene blue to FAPGG metabolism-surface area product ratio,,,,0.552,,0.0391,0.1235,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours),58114,air oxygen content (12 %) (for 14 days),,methylene blue (10 umol/l) (between 0 and 0 hours),,,, 526,PhysGen Lung data,pulmonary blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,91 days to 77 days,10,,CMO:0000711,methylene blue to FAPGG metabolism-surface area product ratio,,,,0.431,,0.0289,0.0913,MMO:0000152,isolated perfused lung vascular effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours),58118,air oxygen content (12 %) (for 14 days),,methylene blue (10 umol/l) (between 0 and 0 hours),,,, 522,PhysGen Vascular data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000012,body weight,,,,175.4,g,1.8,5.6,MMO:0000017,whole body digital scale,,,,,,,control condition (for 21 days),55426,control condition (for 21 days),,,,,, 522,PhysGen Vascular data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000012,body weight,,,,236.5,g,5.1,16.1,MMO:0000017,whole body digital scale,,,,,,,control condition (for 21 days),55437,control condition (for 21 days),,,,,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000724,concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50),,,,2.4364,E-7mole,0.9738,3.0794,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),56531,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours), 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,9,,CMO:0000724,concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50),,,,5.3688,E-7mole,3.012,9.0361,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),56543,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours), 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.8066,,0.0423,0.1269,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),55636,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,9,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.9204,,0.0735,0.2205,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),55648,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000721,concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50),,,,0.0264,umol/l,0.0082,0.0247,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),54685,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,,,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000721,concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50),,,,0.0137,umol/l,0.0021,0.0066,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),54697,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,,,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000728,maximum contractile force per wet weight of aorta,,,,1.226,g/mg,0.1664,0.5264,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours),55799,potassium ion (80 mmol/l) (for 0.2 hours),phenylephrine (10 umol/l) (for 0.2 hours),,,,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000728,maximum contractile force per wet weight of aorta,,,,1.058,g/mg,0.134,0.4237,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours),57345,controlled sodium content diet (4 %) (for 21 days),,potassium ion (80 mmol/l) (for 0.2 hours),phenylephrine (10 umol/l) (for 0.2 hours),,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000728,maximum contractile force per wet weight of aorta,,,,0.947,g/mg,0.0888,0.2808,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours),57357,controlled sodium content diet (4 %) (for 21 days),,potassium ion (80 mmol/l) (for 0.2 hours),phenylephrine (10 umol/l) (for 0.2 hours),,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000731,acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,,,78.8,%,5.8019,18.3473,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),54791,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours), 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,9,,CMO:0000731,acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,,,61.7778,%,8.2996,24.8987,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),54803,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours), 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000728,maximum contractile force per wet weight of aorta,,,,0.803,g/mg,0.1321,0.4179,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours),55811,potassium ion (80 mmol/l) (for 0.2 hours),phenylephrine (10 umol/l) (for 0.2 hours),,,,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000724,concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50),,,,1.6192,E-7mole,0.1476,0.4428,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),55905,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,9,,CMO:0000724,concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50),,,,1.354,E-7mole,0.2511,0.7533,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),55917,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.8058,,0.1186,0.375,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),56926,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours), 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,9,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.6664,,0.1884,0.5652,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),56938,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours), 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000721,concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50),,,,0.0193,umol/l,0.0055,0.0164,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),54917,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000721,concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50),,,,0.0119,umol/l,0.0038,0.0121,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),54929,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000722,logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50),,EC50 value is moles/liter,,-7.8689,,0.1322,0.3967,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),56116,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000722,logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50),,EC50 value is moles/liter,,-8.0684,,0.1093,0.3457,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),56128,controlled sodium content diet (4 %) (for 21 days),,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,, 522,PhysGen Vascular data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,10,,CMO:0000012,body weight,,,,179,g,4.4,14.0,MMO:0000017,whole body digital scale,,,,,,,controlled sodium content diet (4 %) (for 21 days),55192,controlled sodium content diet (4 %) (for 21 days),,,,,, 522,PhysGen Vascular data,body mass,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000012,body weight,,,,267.6,g,7.8,24.8,MMO:0000017,whole body digital scale,,,,,,,controlled sodium content diet (4 %) (for 21 days),55203,controlled sodium content diet (4 %) (for 21 days),,,,,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000722,logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50),,EC50 value is moles/liter,,-7.5268,,0.2122,0.6367,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),55286,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,,,, 522,PhysGen Vascular data,vasoconstriction trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,10,,CMO:0000722,logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50),,EC50 value is moles/liter,,-7.9051,,0.0625,0.1975,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours),55298,phenylephrine (0-300 umol/l) ,drug dose time series (for 1.2 hours),,,,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,84 days to 70 days,9,,CMO:0000731,acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,,,75.7778,%,6.0548,18.1644,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),57235,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,, 522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,84 days to 70 days,9,,CMO:0000731,acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,,,76.6667,%,4.6577,13.9732,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),57247,phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,,